Adrenal gland- Dsg3 negative adrenocortical adenoma.
Adrenal gland- Dsg3 negative adrenocortical adenoma. 
Anal canal- Squamous cell carcinoma with strong Dsg3 immunostaining of tumor cells.
Anal canal- Squamous cell carcinoma with strong Dsg3 immunostaining of tumor cells. 
Breast- Dsg3 negative invasive breast cancer of no special type (NST).
Breast- Dsg3 negative invasive breast cancer of no special type (NST).
Breast- Invasive breast cancer of no special type (NST) exhibiting a strong membranous Dsg3 immunostaining of tumor cells.
Breast- Invasive breast cancer of no special type (NST) exhibiting a strong membranous Dsg3 immunostaining of tumor cells. 
Colon- Colorectal adenocarcinoma with weak to moderate membranous Dsg3 immunostaining of tumor cells.
Colon- Colorectal adenocarcinoma with weak to moderate membranous Dsg3 immunostaining of tumor cells.
Colon- Dsg3 negative colorectal adenocarcinoma.
Colon- Dsg3 negative colorectal adenocarcinoma.
Esophagus- Squamous cell carcinoma with strong Dsg3 positivity of tumor cells.
Esophagus- Squamous cell carcinoma with strong Dsg3 positivity of tumor cells.
Kidney- Dsg3 negative clear cell renal cell carcinoma.
Kidney- Dsg3 negative clear cell renal cell carcinoma.
Liver- Dsg3 negative hepatocellular carcinoma.
Liver- Dsg3 negative hepatocellular carcinoma. 
Lung- Dsg3 negative adenocarcinoma.
Lung- Dsg3 negative adenocarcinoma.
Lung- Squamous cell carcinoma with strong membranous Dsg3 immunostaining of all tumor cells.
Lung- Squamous cell carcinoma with strong membranous Dsg3 immunostaining of all tumor cells.
Lymph node- Dsg3 negative Hodgkin’s lymphoma.
Lymph node- Dsg3 negative Hodgkin’s lymphoma. 
Oral cavity- Squamous cell carcinoma with strong predominantly membranous Dsg3 immunostaining of tumor cells.
Oral cavity- Squamous cell carcinoma with strong predominantly membranous Dsg3 immunostaining of tumor cells. 
Ovary- Dsg3 negative clear cell carcinoma.
Ovary- Dsg3 negative clear cell carcinoma.
Ovary- Dsg3 negative endometroid carcinoma.
Ovary- Dsg3 negative endometroid carcinoma.
Ovary- Dsg3 negative serous high-grade carcinoma.
Ovary- Dsg3 negative serous high-grade carcinoma.
Pancreas- Dsg3 negative ductal adenocarcinoma.
Pancreas- Dsg3 negative ductal adenocarcinoma.
Penis- Squamous cell carcinoma with intense membranous Dsg3 immunostaining of tumor cells.
Penis- Squamous cell carcinoma with intense membranous Dsg3 immunostaining of tumor cells. 
Prostate- Dsg3 negative adenocarcinoma (Gleason 3+3=6).
Prostate- Dsg3 negative adenocarcinoma (Gleason 3+3=6).
Salivary gland- Warthin tumor with strong Dsg3 immunostaining of tumor cells.
Salivary gland- Warthin tumor with strong Dsg3 immunostaining of tumor cells. 
Skin- Basal cell carcinoma showing a weak Dsg3 immunostaining of tumor cells.
Skin- Basal cell carcinoma showing a weak Dsg3 immunostaining of tumor cells. 
Skin- Dsg3 negative basal cell carcinoma.
Skin- Dsg3 negative basal cell carcinoma. 
Skin- Dsg3 negative malignant melanoma.
Skin- Dsg3 negative malignant melanoma. 
Skin- Dsg3 negative Merkel cell carcinoma.
Skin- Dsg3 negative Merkel cell carcinoma. 
Skin- Squamous cell carcinoma with strong Dsg3 immunostaining of tumor cells.
Skin- Squamous cell carcinoma with strong Dsg3 immunostaining of tumor cells. 
Stomach- Dsg3 negative gastric adenocarcinoma.
Stomach- Dsg3 negative gastric adenocarcinoma.
Stomach- Dsg3 negative gastrointestinal stromal tumor (GIST).
Stomach- Dsg3 negative gastrointestinal stromal tumor (GIST). 
Stomach- Gastric adenocarcinoma (intestinal type) showing focal weak to moderate membranous Dsg3 immunostaining of tumor cells.
Stomach- Gastric adenocarcinoma (intestinal type) showing focal weak to moderate membranous Dsg3 immunostaining of tumor cells.
Testis- Dsg3 negative seminoma.
Testis- Dsg3 negative seminoma.
Thymus- Thymoma with moderate to strong membranous Dsg3 immunostaining of epithelial tumor cells.
Thymus- Thymoma with moderate to strong membranous Dsg3 immunostaining of epithelial tumor cells. 
Thyroid- Dsg3 negative papillary carcinoma.
Thyroid- Dsg3 negative papillary carcinoma. 
Urinary bladder- Dsg3 negative muscle-invasive urothelial carcinoma.
Urinary bladder- Dsg3 negative muscle-invasive urothelial carcinoma. 
Urinary bladder- Squamous cell carcinoma showing strong membranous Dsg3 immunostaining.
Urinary bladder- Squamous cell carcinoma showing strong membranous Dsg3 immunostaining.
Uterus, cervix- Squamous cell carcinoma with variable membranous Dsg3 immunostaining of tumor cells. Staining is only weak in basal tumor cells.
Uterus, cervix- Squamous cell carcinoma with variable membranous Dsg3 immunostaining of tumor cells. Staining is only weak in basal tumor cells. 
Vagina- Squamous cell carcinoma with weak to moderate Dsg3 immunostaining of tumor cells.
Vagina- Squamous cell carcinoma with weak to moderate Dsg3 immunostaining of tumor cells. 
Vulva- Squamous cell carcinoma showing a strong, predominantly membranous Dsg3 immunostaining of tumor cells.
Vulva- Squamous cell carcinoma showing a strong, predominantly membranous Dsg3 immunostaining of tumor cells.